It is typically administered via a weekly injection, which helps regulate insulin secretion, slows gastric emptying, and reduces food intake
Weekly injections of semaglutide have since also been shown to promote significant weight loss (15% reduction in body weight compared to 2.4% with placebo) in patients without diabetes, and has been approved for the treatment of obesity [96, 98]
These actions can lead to weight loss, which is why GLP-1 medications are also prescribed for weight management, even in people without diabetes
In HFrEF, the administration of GLP-1 RAs did not improve LV systolic function
Compounded oral semaglutide exists at prices but carries the same availability and quality concerns described above arguably more so since oral compounding adds another layer of variability The Cost That Never Stops
Unfortunately, very few people qualify for insurance coverage for these drugs, and due to manufacturing shortages, theyre even harder to come by